See more : Anew Medical, Inc. (WENA) Income Statement Analysis – Financial Results
Complete financial analysis of BrightSpring Health Services, Inc. Common Stock (BTSG) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of BrightSpring Health Services, Inc. Common Stock, a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
You may be interested
- Hamak Gold Limited (HAMA.L) Income Statement Analysis – Financial Results
- argenx SE (0QW0.L) Income Statement Analysis – Financial Results
- Shakti Pumps (India) Limited (SHAKTIPUMP.BO) Income Statement Analysis – Financial Results
- Gulf Keystone Petroleum Limited (GKP.L) Income Statement Analysis – Financial Results
- 37 Capital Inc. (HHHEF) Income Statement Analysis – Financial Results
BrightSpring Health Services, Inc. Common Stock (BTSG)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.brightspringhealth.com
About BrightSpring Health Services, Inc. Common Stock
BrightSpring Health Services, Inc. operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations. It serves patients through clinical providers and pharmacists. BrightSpring Health Services, Inc. was formerly known as Phoenix Parent Holdings Inc. and changed its name to BrightSpring Health Services, Inc. in May 2021. The company was founded in 1974 and is based in Louisville, Kentucky.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 8.83B | 7.72B | 6.70B | 5.58B | 4.53B | 2.54B |
| Cost of Revenue | 7.39B | 6.37B | 5.45B | 4.53B | 3.69B | 2.16B |
| Gross Profit | 1.43B | 1.35B | 1.25B | 1.05B | 833.91M | 375.91M |
| Gross Profit Ratio | 16.24% | 17.54% | 18.64% | 18.79% | 18.43% | 14.82% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.29B | 1.06B | 1.01B | 774.93M | 696.36M | 301.06M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 1.29B | 1.06B | 1.01B | 774.93M | 696.36M | 301.06M |
| Cost & Expenses | 8.68B | 7.42B | 6.46B | 5.31B | 4.39B | 2.46B |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 324.59M | 233.58M | 165.32M | 138.95M | 166.89M | 74.61M |
| Depreciation & Amortization | 202.34M | 203.97M | 199.16M | 181.50M | 154.87M | 81.17M |
| EBITDA | 349.52M | 500.00M | 433.34M | 346.69M | 292.41M | 156.02M |
| EBITDA Ratio | 3.96% | 6.48% | 6.47% | 8.16% | 6.46% | 6.15% |
| Operating Income | 147.18M | 296.03M | 234.18M | 273.81M | 137.55M | 74.85M |
| Operating Income Ratio | 1.67% | 3.83% | 3.50% | 4.91% | 3.04% | 2.95% |
| Total Other Income/Expenses | -324.59M | -341.78M | -165.32M | -138.95M | -241.13M | -85.68M |
| Income Before Tax | -177.41M | -45.75M | 68.86M | 26.24M | -103.58M | -10.83M |
| Income Before Tax Ratio | -2.01% | -0.59% | 1.03% | 0.47% | -2.29% | -0.43% |
| Income Tax Expense | -20.58M | 8.47M | 17.60M | 5.09M | -32.49M | -3.21M |
| Net Income | -154.60M | -53.91M | 49.80M | 20.81M | -72.38M | -7.62M |
| Net Income Ratio | -1.75% | -0.70% | 0.74% | 0.37% | -1.60% | -0.30% |
| EPS | -0.90 | -0.31 | 0.29 | 2.79 | -10.26 | -1.57 |
| EPS Diluted | -0.90 | -0.31 | 0.29 | 2.78 | -10.26 | -1.57 |
| Weighted Avg Shares Out | 171.19M | 171.19M | 171.19M | 7.45M | 7.06M | 4.85M |
| Weighted Avg Shares Out (Dil) | 171.19M | 171.19M | 171.19M | 7.49M | 7.06M | 4.85M |
BrightSpring Health Services, Inc. to Announce First Quarter 2024 Financial Results on May 2, 2024, and Participate in the Bank of America 2024 Healthcare Conference
LOUISVILLE, Ky., April 09, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today that it plans to release its first quarter 2024 financial results on Thursday, May 2, 2024, prior to the Company's...
BrightSpring Health Services Applauds Hundreds of Award-Winning Employees for their Recognition of Outstanding Service and Care
LOUISVILLE, Ky., April 04, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or “the Company”) (NASDAQ: BTSG) applauds its most recent employees and programs for their dedicated service, care, and innovation, which has resulted in ongoing and additional national...
BrightSpring Health Services Announces Recent Acquisitions That Continue to Drive Growth and Value
LOUISVILLE, Ky., March 26, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or “BrightSpring Health Services”) (NASDAQ: BTSG), a leading provider of home and community-based health services for complex populations, today announced several recent tuck-in acquisitions within its service...
BrightSpring Welcomes Olivia Kirtley to Board of Directors
Kirtley brings deep business experience and financial expertise to further Company's mission Kirtley brings deep business experience and financial expertise to further Company's mission
BrightSpring Health Services' Specialty Pharmacy Onco360® Celebrates Excellent Patient Care and Preferred Pharmacy Status
LOUISVILLE, Ky., March 14, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services (“BrightSpring” or “BrightSpring Health Services”) (NASDAQ: BTSG) announced today that its company, Onco360®, one of the nation's largest independent oncology pharmacies, is now the national specialty pharmacy network partner...
BrightSpring Health Services, Inc. (BTSG) Q4 2023 Earnings Call Transcript
BrightSpring Health Services, Inc. (BTSG) Q4 2023 Earnings Call Transcript
BrightSpring Health Services, Inc. Reports Financial Results for Fourth Quarter and Full Year 2023 and Provides Full Year 2024 Guidance
LOUISVILLE, Ky., Feb. 29, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today financial results for the fourth quarter and full year ended December 31, 2023.
BrightSpring Health Services, Inc. to Announce Fourth Quarter and Full Year 2023 Financial Results and Hold Investor Conference Call on February 29, 2024
LOUISVILLE, Ky., Feb. 15, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today that it plans to release its fourth quarter and full year 2023 financial results on Thursday, February 29, 2024, prior...
IPO freeze gives way to cautious optimism as dealmakers see signs of a thaw
Private-equity and venture-capital firms flourished during the low-interest rate period that followed the 2008 financial crisis with a brisk pace of mergers and acquisitions, as well as a healthy pipeline of initial public offerings.
American Healthcare REIT, Fortegra and Fractyle Health set IPO price ranges as thaw continues
American Healthcare REIT Inc., Fortegra Group Inc. and Fractyle Health Inc. set proposed price ranges in their upcoming initial public offerings on Monday, after a mixed reception to two deals late last week.
Source: https://incomestatements.info
Category: Stock Reports